| abstract |
Described are recombinant MVA viruses that contain foreign genes inserted into the naturally occurring deletion in the MVA genome and are capable of expressing these foreign genes. Described below is the use of these recombinant MVA viruses to produce a polypeptide, e.g. antigens or therapeutic agents, and the use of these viruses for the preparation of recombinant vaccine or viral vector vectors for gene therapy. Please refer to either the infected viruses or vaccines that contain them. \ T |